JAK Inhibitors Are New Category of Drugs for Rheumatoid Arthritis

JAK Inhibitors Are New Category of Drugs for Rheumatoid Arthritis How are JAK inhibitors different from biologic drugs? Here's one difference: one works intracellularly while the other has extracellular targets. READ NOW  READ THESE NEXT Xeljanz Was First JAK Inhibitor Approved in 2012 MORE JAK Inhibitor May Be Combined With Methotrexate MORE The 5 Main Drug Classes Used to Treat Arthritis MORE AN ABOUT.COM BRAND You are receiving this newsletter because you subscribed to the Real Life with Arthritis newsletter. If you wish to unsubscribe, please click here 1500 Broadway, 6th Floor, New York, NY, 10036 © 2017 Verywell.com - All rights reserved. Privacy Policy.